Literature DB >> 11383052

[Therapy of ankylosing spondylitis (AS) with radium chloride (224SpondylAT)].

J Braun1, E M Lemmel, B Manger, R Rau, H Sörensen, J Sieper.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11383052     DOI： 10.1007/s003930170077

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN： 0340-1855            Impact factor:   1.372


× No keyword cloud information.
  5 in total

Review 1.  New treatment options in ankylosing spondylitis: a role for anti-TNFalpha therapy.

Authors:  J Sieper; J Braun
Journal:  Ann Rheum Dis       Date:  2001-11       Impact factor: 19.103

2.  [Which possibilities of nuclear medicine therapy in general practice are available (RSO, Ra-224)?].

Authors:  D Sandrock
Journal:  Z Rheumatol       Date:  2002-08       Impact factor: 1.372

Review 3.  [Epidemiology and prognostic aspects of ankylosing spondylitis].

Authors:  J Braun
Journal:  Radiologe       Date:  2004-03       Impact factor: 0.635

4.  Incidence of leukaemia and other malignant diseases following injections of the short-lived alpha-emitter 224Ra into man.

Authors:  Roland R Wick; M J Atkinson; E A Nekolla
Journal:  Radiat Environ Biophys       Date:  2009-05-28       Impact factor: 1.925

Review 5.  Therapy of ankylosing spondylitis and other spondyloarthritides: established medical treatment, anti-TNF-alpha therapy and other novel approaches.

Authors:  Juergen Braun; Joachim Sieper
Journal:  Arthritis Res       Date:  2002-08-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.